Why China for sleep medicine?

Three reasons: (1) Volume — China runs the world's largest OSA cohort by absolute numbers (estimated 200M+ adults at risk), with sleep medicine departments at unmatched scale; (2) Cost — full attended polysomnography costs $280–$550 vs $1,500–$5,000 in the US; (3) Equipment — major CPAP and BiPAP brands (ResMed, Philips Respironics, Fisher & Paykel) are NMPA-listed at 30–50% below US pricing, and complex multi-modality surgical OSA options are available at flagship ENT centres.

What does a sleep evaluation include?

Standard pathway: sleep history, Epworth Sleepiness Scale, STOP-BANG (or NoSAS), Berlin Questionnaire screening; full-night attended polysomnography (Type I, gold standard) or home sleep test (Type III); for OSA: AHI / RDI / OSA severity grading, oxygen desaturation analysis, positional analysis; for non-OSA: sleep latency, REM architecture, parasomnia analysis. Bilingual report mapped to AASM / Chinese Sleep Society guidance.

What about CPAP — buying and continuing at home?

CPAP and BiPAP machines from ResMed, Philips Respironics and Fisher & Paykel are NMPA-listed at substantially lower prices than US — typical auto-CPAP $400–$900 vs $800–$1,500 in the US. Same machines, same masks. We provide bilingual prescription for home insurance reimbursement; you can also continue with a US / EU prescriber for ongoing CPAP support if preferred. Domestic Chinese CPAP brands (BMC, Yuwell, Mediano) are also available at $200–$500.

What about surgical OSA options?

Multi-level surgery for OSA at flagship ENT centres: uvulopalatopharyngoplasty (UPPP) ± tonsillectomy; hyoid suspension; tongue-base reduction (radiofrequency, partial glossectomy); genioglossus advancement; maxillomandibular advancement (MMA, the most effective surgical option for severe OSA); pediatric adenotonsillectomy. Hypoglossal nerve stimulator (Inspire-equivalent) availability in mainland China is limited; we identify centres with the technology when relevant.

CBT-I (cognitive behavioural therapy for insomnia) is first-line per AASM 2021 guidance and increasingly available in English / Chinese at sleep medicine departments and behavioural sleep medicine specialists. Pharmacotherapy as adjunct: short-term hypnotic if needed (zolpidem, zopiclone), melatonin for circadian disruption, doxepin or low-dose trazodone for sleep maintenance. Long-term hypnotic use is discouraged.

What about narcolepsy and rare sleep disorders?

Narcolepsy diagnosis: PSG + multiple sleep latency test (MSLT). Treatment: modafinil (NMPA-approved), pitolisant (NMPA approval pending), sodium oxybate (limited NMPA availability). Rare sleep disorders (REM sleep behaviour disorder, central hypersomnia, idiopathic hypersomnia, restless legs syndrome) are managed at academic sleep centres. Pediatric sleep disorders coordinated with pediatric subspecialists at Children's Hospital partners.

Sleep medicine · 2026

Sleep medicine in China,
diagnose and treat OSA + insomnia.

Full-night polysomnography from $280. CPAP titration, oral appliance therapy, surgical OSA options, narcolepsy and insomnia care at Class A sleep centres. Bilingual sleep report and home-team handover.

Get a written quote Top sleep centres

$280–550

PSG (sleep study)

Full-night attended polysomnography

Partner clinic quotes 2024

$180–350

Home sleep test

WatchPAT / Belun for screening OSA

Partner clinic quotes 2024

Class A

Sleep centres

PUMC, Shanghai Sixth, Beijing Tongren ENT sleep

NHC ratings

CPAP

ResMed / Philips

Same major brands at substantially lower NMPA pricing

NMPA listings

Bilingual

PSG + report

AHI, RDI, SpO2 nadir, sleep architecture, recommendations

Service standard

Surgical

UPPP / MMA / Inspire

Multi-level surgical options at flagship centres

Centre programs

Tiers & pricing

Six tiers, transparent pricing.

Diagnostic

Sleep consultation + PSG

Sleep history, ESS / STOP-BANG screening, full-night attended polysomnography.

$450–950

OSA standard

CPAP titration + therapy

PSG-based titration + machine + 4-week follow-up. Auto-titrating CPAP / BiPAP.

$650–1,400 + machine

Mild OSA

Oral appliance therapy

Custom-fitted mandibular advancement device for mild-to-moderate OSA, CPAP intolerance.

$1,200–2,800

Surgical

Surgical OSA (UPPP / MMA)

Uvulopalatopharyngoplasty, hyoid suspension, maxillomandibular advancement at ENT centres.

$5,500–22,000

Specialist

Inspire-equivalent neurostim

Hypoglossal nerve stimulator (where available) for moderate-to-severe OSA failing CPAP.

$28,000–45,000

Non-OSA

Insomnia + narcolepsy

CBT-I, sleep hygiene, pharmacotherapy. Narcolepsy: modafinil, sodium oxybate (limited NMPA).

Quoted on case

Top hospitals

Six centres
open to international patients.

Beijing

PUMC Sleep Medicine 北京协和医院

Academic sleep medicine · all PSG variants · complex sleep disorders

Shanghai

Shanghai Sixth People's Hospital Sleep 上海第六人民医院

Class A · large sleep centre · diabetes-OSA integration

Beijing

Beijing Tongren Hospital ENT Sleep 北京同仁医院

Class A · surgical OSA program (UPPP, MMA, hyoid) · ENT integration

Shanghai

Huashan Sleep + Psychiatry 华山医院

Class A · neurology + sleep · narcolepsy and parasomnia expertise

Multi-city

United Family Hospitals 和睦家

JCI · expat-focused · routine OSA + CPAP follow-up

Multi-city

Beijing Boren + Shanghai Riemser

Private sleep specialty · home sleep testing + premium CPAP

FAQ

Frequently asked questions.

Why China for sleep medicine?: Three reasons: (1) Volume — China runs the world's largest OSA cohort by absolute numbers (estimated 200M+ adults at risk), with sleep medicine departments at unmatched scale; (2) Cost — full attended polysomnography costs $280–$550 vs $1,500–$5,000 in the US; (3) Equipment — major CPAP and BiPAP brands (ResMed, Philips Respironics, Fisher & Paykel) are NMPA-listed at 30–50% below US pricing, and complex multi-modality surgical OSA options are available at flagship ENT centres.
What does a sleep evaluation include?: Standard pathway: sleep history, Epworth Sleepiness Scale, STOP-BANG (or NoSAS), Berlin Questionnaire screening; full-night attended polysomnography (Type I, gold standard) or home sleep test (Type III); for OSA: AHI / RDI / OSA severity grading, oxygen desaturation analysis, positional analysis; for non-OSA: sleep latency, REM architecture, parasomnia analysis. Bilingual report mapped to AASM / Chinese Sleep Society guidance.
What about CPAP — buying and continuing at home?: CPAP and BiPAP machines from ResMed, Philips Respironics and Fisher & Paykel are NMPA-listed at substantially lower prices than US — typical auto-CPAP $400–$900 vs $800–$1,500 in the US. Same machines, same masks. We provide bilingual prescription for home insurance reimbursement; you can also continue with a US / EU prescriber for ongoing CPAP support if preferred. Domestic Chinese CPAP brands (BMC, Yuwell, Mediano) are also available at $200–$500.
What about surgical OSA options?: Multi-level surgery for OSA at flagship ENT centres: uvulopalatopharyngoplasty (UPPP) ± tonsillectomy; hyoid suspension; tongue-base reduction (radiofrequency, partial glossectomy); genioglossus advancement; maxillomandibular advancement (MMA, the most effective surgical option for severe OSA); pediatric adenotonsillectomy. Hypoglossal nerve stimulator (Inspire-equivalent) availability in mainland China is limited; we identify centres with the technology when relevant.
What about insomnia?: CBT-I (cognitive behavioural therapy for insomnia) is first-line per AASM 2021 guidance and increasingly available in English / Chinese at sleep medicine departments and behavioural sleep medicine specialists. Pharmacotherapy as adjunct: short-term hypnotic if needed (zolpidem, zopiclone), melatonin for circadian disruption, doxepin or low-dose trazodone for sleep maintenance. Long-term hypnotic use is discouraged.
What about narcolepsy and rare sleep disorders?: Narcolepsy diagnosis: PSG + multiple sleep latency test (MSLT). Treatment: modafinil (NMPA-approved), pitolisant (NMPA approval pending), sodium oxybate (limited NMPA availability). Rare sleep disorders (REM sleep behaviour disorder, central hypersomnia, idiopathic hypersomnia, restless legs syndrome) are managed at academic sleep centres. Pediatric sleep disorders coordinated with pediatric subspecialists at Children's Hospital partners.

Related guides

Diabetes Care

OSA and type 2 diabetes are tightly linked — comprehensive workup.

Read the guide

Bariatric Surgery

Significant weight loss often improves or resolves OSA.

Read the guide

ENT Surgery

Surgical OSA options including UPPP, MMA, hyoid.

Read the guide

Longevity Medicine

Sleep is a core pillar of healthspan.

Read the guide

Records Translation

Bilingual PSG and CPAP prescription.

Read the guide

Second Opinion

Independent sleep medicine second opinion from $250.

Read the guide

Want a sleep study slot
+ written report?

Send us your sleep history (or just complete the STOP-BANG questionnaire). We coordinate full-night PSG at a partner Class A centre with bilingual report and CPAP / surgical / behavioural recommendations.

Request a quote See top hospitals

This page is for general information only and does not constitute medical advice. Severe sleepiness while driving, witnessed apnea with cardiac symptoms, or oxygen desaturation < 80% require urgent local medical evaluation.

Sleep medicine in China,diagnose and treat OSA + insomnia.

Six tiers, transparent pricing.

Sleep consultation + PSG

CPAP titration + therapy

Oral appliance therapy

Surgical OSA (UPPP / MMA)

Inspire-equivalent neurostim

Insomnia + narcolepsy

Six centresopen to international patients.

PUMC Sleep Medicine 北京协和医院

Shanghai Sixth People's Hospital Sleep 上海第六人民医院

Beijing Tongren Hospital ENT Sleep 北京同仁医院

Huashan Sleep + Psychiatry 华山医院

United Family Hospitals 和睦家

Beijing Boren + Shanghai Riemser

Frequently asked questions.

Related guides

Diabetes Care

Bariatric Surgery

ENT Surgery

Longevity Medicine

Records Translation

Second Opinion

Want a sleep study slot+ written report?

Sleep medicine in China,
diagnose and treat OSA + insomnia.

Six centres
open to international patients.

Want a sleep study slot
+ written report?